• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    KKR & Co. Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8/7/25 4:37:55 PM ET
    $KKR
    Investment Managers
    Finance
    Get the next $KKR alert in real time by email
    false000140491200014049122025-08-042025-08-040001404912us-gaap:CommonStockMember2025-08-042025-08-040001404912kkr:Six25SeriesDMandatoryConvertiblePreferredStockMember2025-08-042025-08-040001404912kkr:Six875SubordinatedNotesDue2065Member2025-08-042025-08-040001404912kkr:Four625SubordinatedNotesDue2061OfKKRGroupFinanceCoIXLLCMember2025-08-042025-08-04

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
     


    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported): August 4, 2025

    KKR & CO. INC.
    (Exact name of registrant as specified in its charter)
     
    Delaware
    001-34820
    88-1203639
    (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

    30 Hudson Yards
    New York, New York
     
    10001
    (Address of principal executive offices)   (Zip Code)
     
     (212) 750-8300
    (Registrant’s telephone number, including area code)
     
    NOT APPLICABLE
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
     
    Trading symbol(s)
     
    Name of each exchange on which registered
    Common Stock
     
    KKR
     
    New York Stock Exchange
    6.25% Series D Mandatory Convertible Preferred Stock
     
    KKR PR D
     
    New York Stock Exchange
    4.625% Subordinated Notes due 2061 of KKR Group Finance Co. IX LLC
     
    KKRS
     
    New York Stock Exchange
    6.875% Subordinated Notes due 2065
     
    KKRT
     
    New York Stock Exchange
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Sec.230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Sec.240.12b-2 of this chapter).
     
    ☐
    Emerging growth company
              
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



    Item 1.01
    Entry into a Material Definitive Agreement.
     
    The information set forth below under Item 2.03 of this Report on Form 8-K is hereby incorporated by reference into this Item 1.01.
     
    Item 2.03
    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
     
    On August 7, 2025, KKR & Co. Inc. (the “Issuer”) completed the offering of $900,000,000 aggregate principal amount of its 5.100% Senior Notes due 2035 (the “Notes”). The Notes are guaranteed by KKR Group Partnership L.P., a subsidiary of the Issuer (the “Guarantor”). The Notes were issued pursuant to an indenture (the “Base Indenture”) dated May 28, 2025 between the Issuer and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), as supplemented by a second supplemental indenture, dated August 7, 2025 (the “Second Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), among the Issuer, the Guarantor and the Trustee.
     
    The Notes bear interest at a rate of 5.100% per annum and will mature on August 7, 2035 unless earlier redeemed. Interest on the Notes accrues from August 7, 2025 and is payable semi-annually in arrears on February 7 and August 7 of each year, commencing on February 7, 2026 and ending on the maturity date. The Notes are unsecured and unsubordinated obligations of the Issuer. The Notes are fully and unconditionally guaranteed (the “Guarantee”), on an unsubordinated unsecured basis, by the Guarantor.
     
    The Indenture includes covenants, including limitations on the Issuer’s and the Guarantor’s ability to, subject to exceptions, incur indebtedness secured by liens on voting stock or profit participating equity interests of their subsidiaries or merge, consolidate or sell, transfer or convey all or substantially all of their assets. The Indenture also provides for events of default and further provides that the Trustee or the holders of not less than 25% in aggregate principal amount of the outstanding Notes may declare the Notes immediately due and payable upon the occurrence and during the continuance of any event of default after expiration of any applicable grace period. In the case of specified events of bankruptcy, insolvency, receivership or reorganization, the principal amount of the Notes and any accrued and unpaid interest on the Notes automatically become due and payable. Prior to May 7, 2035 (three months prior to the maturity date of the Notes), the Notes may be redeemed at the Issuer’s option in whole or in part, at any time and from time to time, at the make-whole redemption price set forth in the Notes. On or after May 7, 2035 (three months prior to the maturity date of the Notes), the Notes may be redeemed at the Issuer’s option in whole or in part, at any time and from time to time, at par plus any accrued and unpaid interest on the Notes redeemed to, but not including, the date of redemption. If a change of control repurchase event (as defined in the Indenture) occurs, the Issuer must offer to repurchase the Notes at a repurchase price in cash equal to 101% of the aggregate principal amount of the Notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including, the date of repurchase.
     
    The preceding is a summary of the terms of the Base Indenture, the Second Supplemental Indenture and the form of the Notes, and is qualified in its entirety by reference to the Base Indenture filed as Exhibit 4.1 to this report, the Second Supplemental Indenture filed as Exhibit 4.2 to this report, and the form of the Notes filed as Exhibit 4.3 to this report and incorporated herein by reference as though they were fully set forth herein.
     
    Item 8.01
    Other Events.
     
    On August 4, 2025, the Issuer and the Guarantor entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., KKR Capital Markets LLC and UBS Securities LLC, as representatives of the underwriters (collectively, the “Underwriters”), to issue and sell the Notes. The Underwriting Agreement contains certain customary representations, warranties and agreements by the Issuer and the Guarantor, including indemnification of the Underwriters.
     
    The Notes were issued pursuant to a registration statement on Form S-3 (Registration No. 333-279233) and a related prospectus dated May 8, 2024, including the related prospectus supplement dated August 4, 2025 and filed with the Securities and Exchange Commission. The Underwriting Agreement is attached hereto as Exhibit 1.1 and is incorporated herein by reference. The foregoing description of the terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit.
     
    Copies of the opinions of Simpson Thacher & Bartlett LLP and the Maples Group, counsel to the Issuer and the Guarantor, relating to the legality of the Notes and the Guarantee are filed as Exhibits 5.1 and 5.2 hereto, respectively.
     
    Item 9.01
    Financial Statements and Exhibits.
     
    (d)
    Exhibits.
     
    The following documents are herewith filed or furnished as exhibits to this Current Report on Form 8-K:
     

    Exhibit No.
     
    Exhibit Description
    1.1
     
    Underwriting Agreement dated as of August 4, 2025 among the Issuer, the Guarantor and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., KKR Capital Markets LLC and UBS Securities LLC, as representatives of the Underwriters.
    4.1
     
    Indenture dated as of May 28, 2025 between the Issuer and the Trustee (incorporated by reference to Exhibit 4.1 to the KKR & Co. Inc. Current Report on Form 8-K filed on May 28, 2025).
    4.2
     
    Second Supplemental Indenture dated as of August 7, 2025 among the Issuer, the Guarantor and the Trustee.
    4.3
     
    Form of 5.100% Senior Note due 2035 (included in Exhibit 4.2 hereto).
    5.1
     
    Opinion of Simpson Thacher & Bartlett LLP.
    5.2
     
    Opinion of the Maples Group.
    104
     
    Cover Page Interactive Data File, formatted in Inline XBRL


    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    KKR & CO. INC.
         
    Date: August 7, 2025
    By:
    /s/ Christopher Lee
     
    Name:
    Christopher Lee
     
    Title:
    Secretary



    Get the next $KKR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KKR

    DatePrice TargetRatingAnalyst
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    7/9/2025$142.00Buy → Hold
    HSBC Securities
    6/30/2025$150.00Overweight
    Piper Sandler
    5/14/2025$150.00Equal-Weight → Overweight
    Morgan Stanley
    4/15/2025$119.00Hold → Buy
    HSBC Securities
    3/20/2025$150.00 → $141.00Equal Weight → Overweight
    Wells Fargo
    1/30/2025$173.00Buy → Hold
    HSBC Securities
    9/18/2024$148.00Buy
    HSBC Securities
    More analyst ratings

    $KKR
    SEC Filings

    View All

    SEC Form 10-Q filed by KKR & Co. Inc.

    10-Q - KKR & Co. Inc. (0001404912) (Filer)

    8/8/25 4:43:19 PM ET
    $KKR
    Investment Managers
    Finance

    SEC Form 144 filed by KKR & Co. Inc.

    144 - KKR & Co. Inc. (0001404912) (Subject)

    8/7/25 6:30:10 PM ET
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - KKR & Co. Inc. (0001404912) (Filer)

    8/7/25 4:37:55 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lewin Robert H gifted 2,500 shares, decreasing direct ownership by 0.21% to 1,196,726 units (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    8/15/25 8:00:32 PM ET
    $KKR
    Investment Managers
    Finance

    SEC Form 4 filed by Large owner Kkr Group Partnership L.P.

    4 - KKR & Co. Inc. (0001404912) (Reporting)

    8/14/25 7:00:45 PM ET
    $KKR
    Investment Managers
    Finance

    Co-Chief Executive Officer Bae Joseph Y acquired 1,592 shares (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    8/8/25 8:00:44 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    THL Announces Agreement to Acquire Headlands Research from KKR

    Strategic Partnership to Advance Site Network Expansion and Accelerate Clinical Trial Innovation THL Partners ("THL"), a premier private equity firm investing in middle market growth companies, today announced the entry into a definitive agreement to acquire Headlands Research ("Headlands" or "the Company"), a leading multinational network of clinical trial sites, from funds managed by leading global investment firm KKR. The strategic partnership between THL and Headlands will fuel Headlands' continued expansion, enhance its technology and centralized infrastructure, and further strengthen its ability to deliver high-quality, diverse clinical trial data for pharmaceutical and biotech spon

    8/14/25 9:00:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR Leads Financing for Harvest Partners' Growth Investment in Med-Metrix

    KKR, a leading global investment firm, today announced that credit funds and accounts managed by KKR served as lead investors on a financing to support the growth investment from funds managed by Harvest Partners, LP ("Harvest") in Med-Metrix, LLC ("Med-Metrix" or "the Company"), a leading provider of technology-enabled Revenue Cycle Management ("RCM") solutions. KKR Capital Markets also served as Left Lead Arranger and Bookrunner on the transaction. The Company's management team, led by CEO Joseph Davi, will continue to lead Med-Metrix and remain significant owners of the business. Med-Metrix's prior owner, A&M Capital ("AMC"), will retain a minority stake in the Company and invest addit

    8/8/25 7:00:00 AM ET
    $KKR
    Investment Managers
    Finance

    FS KKR Capital Corp. Announces Second Quarter 2025 Results

    Declares Third Quarter 2025 Distribution of $0.70 per share PHILADELPHIA and NEW YORK, Aug. 6, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended June 30, 2025, and that its board of directors has declared a third quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended June 30, 2025(1) Net investment income of $0.62 per share, compared to $0.67 per share for the quarter ended March 31, 2025Adjusted net investment income(2) of $0.60 per sha

    8/6/25 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    $KKR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barakett Timothy R bought $4,127,319 worth of shares (35,000 units at $117.92) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    5/27/25 8:01:38 PM ET
    $KKR
    Investment Managers
    Finance

    Director Scully Robert W bought $1,503,733 worth of shares (13,250 units at $113.49) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    5/8/25 7:01:53 PM ET
    $KKR
    Investment Managers
    Finance

    Kkr Alternative Assets Llc bought $50,000,000 worth of Class I Common Stock (1,956,182 units at $25.56) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Reporting)

    6/6/24 9:02:29 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KKR downgraded by Citizens JMP

    Citizens JMP downgraded KKR from Mkt Outperform to Mkt Perform

    7/14/25 8:40:54 AM ET
    $KKR
    Investment Managers
    Finance

    KKR downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $142.00

    7/9/25 10:14:31 AM ET
    $KKR
    Investment Managers
    Finance

    Piper Sandler initiated coverage on KKR with a new price target

    Piper Sandler initiated coverage of KKR with a rating of Overweight and set a new price target of $150.00

    6/30/25 8:01:12 AM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Leadership Updates

    Live Leadership Updates

    View All

    Harley-Davidson Announces Strategic Partnership with KKR and PIMCO

    Unlocks ~$1.25 billion of discretionary cash for Harley-Davidson and transforms Harley-Davidson Financial Services (HDFS) into a capital-light and derisked business that will continue to originate and service both new and existing retail loans Transaction monetizes HDFS through sale of 4.9% common equity interests to each partner and includes the sale of more than $5 billion of retail loan receivables at a premium to par HDFS has agreed to sell approximately two-thirds of retail loans originated by HDFS annually for a minimum period of five years Values HDFS at ~1.75x price to post-transaction book value and reinforces strategic and financial value of HDFS to Harley-Davidson customers, dea

    7/30/25 7:00:00 AM ET
    $HOG
    $KKR
    Motor Vehicles
    Consumer Discretionary
    Investment Managers
    Finance

    Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Healt

    5/16/25 4:10:00 PM ET
    $HSIC
    $KKR
    Medical Specialities
    Health Care
    Investment Managers
    Finance

    KKR Appoints Timothy R. Barakett to Board

    KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket

    3/13/25 4:30:00 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Financials

    Live finance-specific insights

    View All

    FS KKR Capital Corp. Announces Second Quarter 2025 Results

    Declares Third Quarter 2025 Distribution of $0.70 per share PHILADELPHIA and NEW YORK, Aug. 6, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter ended June 30, 2025, and that its board of directors has declared a third quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended June 30, 2025(1) Net investment income of $0.62 per share, compared to $0.67 per share for the quarter ended March 31, 2025Adjusted net investment income(2) of $0.60 per sha

    8/6/25 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. Reports Second Quarter 2025 Results

    KKR & Co. Inc. (NYSE:KKR) today reported its second quarter 2025 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731323085/en/ A conference call to discuss KKR's financial results will be held today, Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Cente

    7/31/25 6:50:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR & Co. Inc. to Announce Second Quarter 2025 Results

    KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the second quarter 2025 on Thursday, July 31, 2025, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Thursday, July 31, 2025 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be a

    7/14/25 4:15:00 PM ET
    $KKR
    Investment Managers
    Finance

    $KKR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    11/12/24 3:50:17 PM ET
    $KKR
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by KKR & Co. Inc.

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    11/4/24 11:48:27 AM ET
    $KKR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by KKR & Co. Inc. (Amendment)

    SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    2/13/24 6:32:37 PM ET
    $KKR
    Investment Managers
    Finance